Alzheimer's Risk May Vary Among Statins Alzheimer's Risk May Vary Among Statins
A new study has suggested that, contrary to expectations, fungus-derived and lipophilic statins may be associated with slightly higher risks for Alzheimer's disease compared with synthetic or hydrophilic agents, with a particular focus on simvastatin.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 21, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Statins Improve Pulmonary Function in Subset of COPD Patients (CME/CE)
(MedPage Today) -- Meta-analysis sheds light on statin use in COPD (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - December 20, 2017 Category: Respiratory Medicine Source Type: news

FloLipid (Simvastatin Oral Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 18, 2017 Category: Drugs & Pharmacology Source Type: news

Erectile dysfunction is red flag for silent early cardiovascular disease
(SAGE) Despite decades long prevention and treatment efforts, cardiovascular (CV) disease continues to be the leading cause of death worldwide. Early detection of CV disease can allow for interventions to prevent heart attack and stroke, including smoking cessation, medications such as a statins, blood pressure control, weight management, exercise, and improved diet. A new study published online first today in the journal Vascular Medicine, focuses on a novel risk factor for cardiovascular disease that rarely receives attention -- erectile dysfunction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 15, 2017 Category: International Medicine & Public Health Source Type: news

Statins Underused in Women With or Without HIV Statins Underused in Women With or Without HIV
Only about a third of women in whom statins are indicated actually receive them, regardless of their HIV status, according to results from the Women's Interagency HIV Study (WIHS).Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - December 14, 2017 Category: Infectious Diseases Tags: Diabetes & Endocrinology News Source Type: news

FloLipid (Simvastatin Oral Suspension) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 14, 2017 Category: Drugs & Pharmacology Source Type: news

Statins May Up Breast Cancer-Specific and Overall Survival Statins May Up Breast Cancer-Specific and Overall Survival
Statins may improve breast cancer outcomes whether women take them before or after their diagnosis and extend overall survival as well.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Statin Use, Colorectal Cancer Recurrence, and Mortality Statin Use, Colorectal Cancer Recurrence, and Mortality
Studies of statin use and colorectal cancer prognosis have shown a beneficial association. Might statins reduce the risk of colorectal cancer recurrence?American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

New study shows HIV-infected women not using statins as recommended
(Mary Ann Liebert, Inc./Genetic Engineering News) A new study has shown that HIV-infected women do not use statins as recommended by the most recent guidelines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 8, 2017 Category: International Medicine & Public Health Source Type: news

Statins, Aspirin Grossly Underused in HIV: US Study Statins, Aspirin Grossly Underused in HIV: US Study
There could be many reasons too few with indications are getting the drugs, including but not limited to poor cross-specialty communication and the changing needs of an aging HIVMedscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 6, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Liver Safety of Statins in Prediabetes or T2DM and NASH Liver Safety of Statins in Prediabetes or T2DM and NASH
What do we know about the long-term hepatic safety of statins in patients with prediabetes or type 2 diabetes and NASH?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Those with a high cardiovascular risk profile should eat dark chocolate with olive oil, new study finds
(Natural News) In recent years, the medical community has put a lot of effort into educating people about reducing their cholesterol levels in order to protect their heart health. Of course, those who do have elevated cholesterol levels are often prescribed statin drugs like Lipitor, Zocor and others to lower these levels. In fact, these... (Source: NaturalNews.com)
Source: NaturalNews.com - December 4, 2017 Category: Consumer Health News Source Type: news

Statins are gateway drugs for Big Pharma: Take one and you'll need four or five more prescriptions for the side effects
(Natural News) One out of every three American adults take statins, and if you think that sounds like good news for statin manufacturers, you’re missing the bigger picture. All of Big Pharma benefits when people take statins. In fact, statins can really be thought of as gateway drugs. After all, they have so many side... (Source: NaturalNews.com)
Source: NaturalNews.com - December 4, 2017 Category: Consumer Health News Source Type: news

National Campaign Tells Patients That This Medication Can Prevent America's Leading Cause of Death
A new survey is the catalyst behind a national education campaign aimed at increasing public understanding of high cholesterol as a key risk factor for heart disease and to providing strategies that empower people to stay on their doctor-prescribed statin medications. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 30, 2017 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news

Class 2 Medicines Recall: Lipitor (Atorvastatin) 80mg film-coated tablets / Atorvastatin 80mg film-coated tablets, Almus livery
The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a class 2 medicines recall for specified batches of Lipitor (Atorvastatin) 80mg film-coated tablets / Atorvastatin 80mg film-c (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 27, 2017 Category: Drugs & Pharmacology Source Type: news

HIV-positive adults are under-treated for cardiovascular problems compared to those without HIV
This study provides evidence that U.S. policymakers and professional societies should focus on improving the quality of the cardiovascular care that people who are HIV-positive receive.AUTHORSStudy authors are Dr. Joseph Ladapo, Dr. Adam Richards, Cassandra DeWitt, Nina Harawa, Steven Shoptaw, Dr. William Cunningham and Dr. John Mafi, all of UCLA. Mafi is also associated with Rand Corporation.JOURNALThestudy is published in the Journal of the American Heart Association.FUNDINGGrants from the National Heart, Lung and Blood Institute, National Institute on Minority Health and Health Disparities, and National Institute of Men...
Source: UCLA Newsroom: Health Sciences - November 22, 2017 Category: Universities & Medical Training Source Type: news

Finance trumps patients at every level – UK healthcare needs an inquiry | Aseem Malhotra
The healthcare system faces a crisis of trust; ill-informed doctors and poor research are harming patientsThe healthcare system is facing failure, rooted in an epidemic of misinformed doctors and patients.During a recent keynote lecture at theBritish Association for Cardiovascular Prevention and Rehabilitation annual conference, I gave the example of a man who had had a heart attack and been given statins and whose months of disabling muscle pain resolved within a week of stopping taking them. His elation was cut short when his GP told him he must never stop his statin or he could die. When the audience was asked to guess ...
Source: Guardian Unlimited Science - November 21, 2017 Category: Science Authors: Aseem Malhotra Tags: Healthcare Network Work practices Workforce GPs and primary care Public health Drugs Science Society NHS Source Type: news

HIV-positive adults receive inferior cardiovascular care compared with those without HIV
(University of California - Los Angeles Health Sciences) People with both HIV and risk factors for heart disease and stroke were less likely to be treated with cholesterol-lowering statin drugs and aspirin than patients without HIV. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 21, 2017 Category: International Medicine & Public Health Source Type: news

New health ALERT: Statins raise risk of diabetes by 30%
TAKING statins can ramp up the risk of diabetes by almost a third, experts have found. (Source: Daily Express - Health)
Source: Daily Express - Health - November 17, 2017 Category: Consumer Health News Source Type: news

When to Start a Statin Is a Preference-Sensitive Decision When to Start a Statin Is a Preference-Sensitive Decision
The author of this commentary explores the complex ethical, practical, and clinical considerations of extending statin treatment to all adults over 40, regardless of cardiovascular risk.Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

AHA: Statins Cut Risk of MACE in Patients With ASCVD Event
Reduced frequency of MACE for patients receiving statins, especially high - intensity statins (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 15, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Critical Care, Emergency Medicine, Neurology, Nursing, Pharmacy, Pulmonology, Conference News, Source Type: news

High-Dose Statins Decrease CV Events in Asian CAD Patients High-Dose Statins Decrease CV Events in Asian CAD Patients
High-dose vs low-dose pitavastatin significantly reduced CV events in patients with stable CAD, according to REAL-CAD, the first randomized trial to assess these issues in Asia.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

New Analyses Presented At AHA 2017 Show Repatha ® (evolocumab) Significantly Reduced Cardiovascular Events In Patients With Peripheral Artery Disease And In Patients With A History Of Heart Attacks
Data Support Use of Repatha to Reduce Risk of Recurrent Cardiovascular Events in Patients With History of Multiple Heart Attacks Additional Analysis Found That Patients With More Recent Heart Attacks Experienced Substantial Risk Reductions With Repatha Repatha Benefit in Peripheral Artery Disease Patients Presented at AHA Scientific Sessions 2017 and Simultaneously Published in "Circulation" THOUSAND OAKS, Calif., Nov. 13, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced five new subgroup analyses from the Repatha® (evolocumab) cardiovascular outcomes study (FOURIER) that s...
Source: Amgen News Release - November 13, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

PCSK9 Inhibitor improves outcomes for patients with peripheral artery disease
(Brigham and Women's Hospital) A new sub-analysis of the FOURIER clinical trial, however, now offers information on the safety and effectiveness of giving the PCSK9 inhibitor evolocumab on top of statin therapy to patients with peripheral artery disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2017 Category: International Medicine & Public Health Source Type: news

People taking statins are less likely to die early
Patients who take statins after suffering a heart attack or stroke are almost 25 per cent less likely to have another one or to die early, researchers at the Heart Institute in Utah have found. (Source: the Mail online | Health)
Source: the Mail online | Health - November 13, 2017 Category: Consumer Health News Source Type: news

Statins can cause muscle DAMAGE: New storm over statins as experts fight over the benefits
STATINS can cause muscle damage and do not extend the lives of low-risk patients, a study has found. (Source: Daily Express - Health)
Source: Daily Express - Health - November 12, 2017 Category: Consumer Health News Source Type: news

Heart attack and stroke patients prescribed statin medication upon discharge have better outcomes
(Intermountain Medical Center) Patients with a prior history of heart attacks or stroke have better outcomes when cholesterol-lowering medications are used after they're discharged from the hospital, according to a new study from the Intermountain Medical Center Heart Institute in Salt Lake City. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 12, 2017 Category: International Medicine & Public Health Source Type: news

New study claims statin drugs raise the risk of type-2 diabetes by almost 30%
(Natural News) Diabetes is one of the most common types of non-communicable diseases that kills millions of people yearly. Recent studies show that taking statins, or drugs that lower blood cholesterol, have a 30 percent chance in increasing the risk of developing type-2 diabetes. Medical personnel have always known of the side effects of these... (Source: NaturalNews.com)
Source: NaturalNews.com - November 9, 2017 Category: Consumer Health News Source Type: news

Statins, Decompensation, and Death in Alcoholic Cirrhosis Statins, Decompensation, and Death in Alcoholic Cirrhosis
Does regular use of statins improve outcomes and reduce mortality in patients with alcoholic cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 9, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Prescriptions of statins are missing the mark: New study finds they are being given to people who don't need them, and not being given to people who do need them
(Natural News) Statins are being prescribed to and misused by patients who are otherwise at low risk of developing heart disease, according to a study carried out by the National Institute for Health and Care Excellence (NICE) in the United Kingdom. This indicates that the drugs are being given to people who do not need them, and not... (Source: NaturalNews.com)
Source: NaturalNews.com - November 6, 2017 Category: Consumer Health News Source Type: news

Tens of thousands of British children 'must go on statins'
As many as 260,000 Britons including 56,000 children under 16 may have inherited high cholesterol levels, known as familial hypercholesterolaemia, or FH. (Source: the Mail online | Health)
Source: the Mail online | Health - November 3, 2017 Category: Consumer Health News Source Type: news

Your NEJM Group Today: Rosacea Clinical Pearls / ACE Inhibitors, Statins & Type 1 Diabetes / Conn. Primary Care Opportunities (FREE)
By the Editors Here's what we chose for you from NEJM Group today:NEJM Resident 360: Clinical Pearls: … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 3, 2017 Category: Primary Care Source Type: news

Inherited high cholesterol should be identified and treated early
NICE updates guidance on familial hypercholesterolaemia Related items fromOnMedica Test all toddlers for inherited high cholesterol, study suggests Cholesterol – monitoring lipid levels and assessing cardiovascular risk Key evidence supporting the lowering of cholesterol Modifying cardiovascular risks and lipid modification Statins benefit children with familial hypercholesterolaemia (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 2, 2017 Category: UK Health Source Type: news

Drugs to treat diabetes are well tolerated in teenagers
Study gives insight into long-term complications Related items fromOnMedica Overview of type 1 diabetes Insulin pumps linked to fewer diabetes complications Study claims medical treatment can reverse type 2 diabetes Statin use link to heightened type 2 diabetes risk in some people Send children with suspected diabetes to hospital immediately, GPs urged (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 2, 2017 Category: UK Health Source Type: news

ACE Inhibitors, Statins in Teen Type 1 Diabetes: No Albumin Drop ACE Inhibitors, Statins in Teen Type 1 Diabetes: No Albumin Drop
"These drugs should remain first-line therapy in adolescents with hypertension or hyperlipidemia, but their use in high-risk individuals to provide cardiorenal protection is more controversial," says the senior study author.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 1, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Oct 27 Cardiology News Oct 27 Cardiology News
Statins tied to diabetes risk and reduced bacterial infections, a novel use for hs-troponin, mitral-regurgitation management, and His-bundle pacing are reviewed in this week's podcast.theheart.org on Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Statins May Help Guard Against S Aureus Bacteremia Statins May Help Guard Against S Aureus Bacteremia
A large Danish study finds a lower risk of community-acquired Staphylococcus aureus bacteremia in statin users, suggesting another pleiotropic effect of the cholesterol-lowering drugs.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 26, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Statins linked to higher type 2 diabetes risk
The use of the drug has been associated with a 30% increase in the risk of developing type 2 diabetes, research inBMJ Open Diabetes Research& Care.Daily Mail (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 26, 2017 Category: Endocrinology Source Type: news

Long-term opioid use does not increase risk of Alzheimer ’s disease
A previous smaller study had suggested that opioids may increase the risk of developing the disease Related items fromOnMedica Antidepressant use increases risk of head injuries in Alzheimer's disease Head injuries linked to Alzheimer ’s and other disorders Statins may influence risk of Alzheimer ’s Dementia now leading cause of death in England and Wales Major study set to detect early signs of Alzheimer ’s (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 26, 2017 Category: UK Health Source Type: news

Do Statins Raise Odds for Type 2 Diabetes?
Title: Do Statins Raise Odds for Type 2 Diabetes?Category: Health NewsCreated: 10/24/2017 12:00:00 AMLast Editorial Review: 10/25/2017 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - October 25, 2017 Category: Endocrinology Source Type: news

Blood-thinning drugs appear to protect against dementia in AF patients
Protective effect seen in patients taking the drugs to reduce the risk of stroke Related items fromOnMedica Heart attack and stroke risk higher with shingles New hope for drugs to prevent some forms of dementia Nine risk factors for dementia identified Taking statins linked to improved heart structure and function Self-managing anticoagulants may cut risks after surgery (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 25, 2017 Category: UK Health Source Type: news

Do Statins Raise Odds for Type 2 Diabetes?
Maybe, but heart benefits likely outweigh any potential risk from the drugs, experts say (Source: WebMD Health)
Source: WebMD Health - October 24, 2017 Category: Consumer Health News Source Type: news

Do Statins Raise Odds for Type 2 Diabetes?
Maybe, but heart benefits likely outweigh any potential risk from the drugs, experts say Source: HealthDay Related MedlinePlus Pages: Diabetes Type 2, Statins (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 24, 2017 Category: Consumer Health News Source Type: news

Do Statins Raise Odds for Type 2 Diabetes?
TUESDAY, Oct. 24, 2017 -- Cholesterol-lowering medications known as statins may lower your risk of heart disease, but also might boost the odds you'll develop type 2 diabetes, new research suggests. " In a group of people at high risk of type 2... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 24, 2017 Category: General Medicine Source Type: news

Statins increase type 2 diabetes risk in ‘susceptible individuals’
Long term use of statins is associated with a 30% heightened risk of developing type 2 diabetes in susceptible individuals, suggests a large study from the US. (Source: Nursing Times)
Source: Nursing Times - October 24, 2017 Category: Nursing Source Type: news

Medical News Today: Statins increase the risk of developing diabetes in at-risk people
Do statins increase the risk of type 2 diabetes? This question has received a great deal of attention. The latest study concludes that the answer is " yes. " (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 24, 2017 Category: Consumer Health News Tags: Statins Source Type: news

Statin Use Raises Diabetes Risk
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 24, 2017 Category: General Medicine Source Type: news

High-risk patients being underprescribed statins, study finds
Cholesterol-lowering drugs are also being overprescribed to people at low risk of having a heart attack or stroke, researchers findStatins are being overprescribed to low-risk groups and underprescribed to high-risk groups, research by the British Journal of General Practice (BJGP) has shown.The report found potential “undertreatment” among people who have at least a 20% chance of cardiovascular disease (CVD) within a decade, who are considered high-risk patients.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 24, 2017 Category: Science Authors: Mattha Busby Tags: Statins Society Heart attack Medical research Stroke UK news Science Source Type: news